Personalized Monitoring of Response to Anti‐Amyloid Therapy in a Real‐World Cohort using Clinical Assessment and Plasma Biomarkers
Plasma p -tau<sub>217</sub> and brief clinical assessments can be used to provide individualized monitoring, and potentially, prediction of treatment response to AAT in real-world settings.
Authors
- Magdalena Korecka (ORCID: https://orcid.org/0000-0003-3129-8295)
- L. Shaw
- Divij Mathew (ORCID: https://orcid.org/0000-0002-8323-7358)
- Corey T. McMillan (ORCID: https://orcid.org/0000-0002-7581-6405)
- David A. Wolk (ORCID: https://orcid.org/0000-0002-3554-3481)
- E. B. Lee
- Laura Schankel
- Alice S Chen-Plotkin
- Valerie E Humphreys
- Danielle Hing
- Dawn Mechanic‐Hamilton
- Christopher D. Brown
- Katheryn A. Q. Cousins
Institutions
- University of Pennsylvania (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70861_108800
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00